Cargando…
PPAR Ligands Function as Suppressors That Target Biological Actions of HMGB1
High mobility group box 1 (HMGB1), which has become one of the most intriguing molecules in inflammatory disorders and cancers and with which ligand-activated peroxisome proliferator-activated receptors (PPARs) are highly associated, is considered as a therapeutic target. Of particular interest is t...
Autores principales: | Ying, Shibo, Xiao, Xiang, Chen, Tianhui, Lou, Jianlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985574/ https://www.ncbi.nlm.nih.gov/pubmed/27563308 http://dx.doi.org/10.1155/2016/2612743 |
Ejemplares similares
-
HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma
por: Wang, Yanbin, et al.
Publicado: (2019) -
Ligand Modulated Antagonism of PPARγ by Genomic and Non-Genomic Actions of PPARδ
por: Gustafsson, Mattias C. U., et al.
Publicado: (2009) -
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases
por: Ying, Shibo, et al.
Publicado: (2017) -
MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma
por: Yan, Jianing, et al.
Publicado: (2018) -
Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer
por: Kang, Rui, et al.
Publicado: (2017)